|
SPCS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.061000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.319400E-01 |
| Normal-vs-Stage2 |
1.610810E-01 |
| Normal-vs-Stage3 |
7.659400E-01 |
| Normal-vs-Stage4 |
4.603200E-01 |
| Stage1-vs-Stage2 |
1.409850E-01 |
| Stage1-vs-Stage3 |
6.806600E-01 |
| Stage1-vs-Stage4 |
4.049800E-01 |
| Stage2-vs-Stage3 |
1.485240E-01 |
| Stage2-vs-Stage4 |
3.804600E-01 |
| Stage3-vs-Stage4 |
3.562400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.716400E-01 |
| Normal-vs-AfricanAmerican |
2.462000E-01 |
| Normal-vs-Asian |
1.372420E-01 |
| Caucasian-vs-AfricanAmerican |
2.575600E-01 |
| Caucasian-vs-Asian |
4.296500E-02 |
| AfricanAmerican-vs-Asian |
4.145700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.470400E-01 |
| Normal-vs-Female |
4.059000E-01 |
| Male-vs-Female |
3.458600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.300400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.367800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.713200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.478000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.119800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.839800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.081600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.429000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.580200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.676800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.957800E-01 |
| Normal-vs-Grade 2 |
5.578000E-01 |
| Normal-vs-Grade 3 |
7.708200E-01 |
| Normal-vs-Grade 4 |
6.098000E-01 |
| Grade 1-vs-Grade 2 |
4.419000E-01 |
| Grade 1-vs-Grade 3 |
3.587800E-01 |
| Grade 1-vs-Grade 4 |
2.283600E-01 |
| Grade 2-vs-Grade 3 |
6.838200E-01 |
| Grade 2-vs-Grade 4 |
2.794000E-01 |
| Grade 3-vs-Grade 4 |
3.568600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.149600E-01 |
| Normal-vs-ccB subtype |
1.780160E-01 |
| ccA subtype-vs-ccB subtype |
2.029800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.633600E-01 |
| Normal-vs-N1 |
2.768600E-01 |
| N0-vs-N1 |
1.906230E-01 |
|
|
